Xu, Zhibiao
Khan, Alveena Nasim
Zhang, Li
Liu, Yuyun
Meng, Yuxiang
Ling, Zijie
Yuan, Sumin
Liu, Su
Zhao, Linlin
Funding for this research was provided by:
Xuzhou Municipal Health Commission Science and Technology Project (XWKYHT20230056)
Construction Project of High Level Hospital of Jiangsu Province (LCZX202505)
Article History
Received: 18 August 2025
Accepted: 30 December 2025
First Online: 14 January 2026
Declarations
:
: This study was a prospective, double-blind, randomized controlled trial, which has been approved by the Ethics Committee of the Affiliated Hospital of Xuzhou Medical University (XYFY2024-KL349-01) and registered at the Chinese Clinical Trial Registry ( , ChiCTR2400088052, registration date: August 9, 2024). It was conducted at the Affiliated Hospital of Xuzhou Medical University from August to December 2024. The trial followed the CONSORT guidelines and Declarations of Helsinki. Informed consent was obtained from all patients.
: Not Applicable.
: The authors declare no competing interests.